Allen Annis's most recent trade in Rein Therapeutics Inc. was a trade of 313,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 30, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rein Therapeutics Inc. | Allen Annis | SVP, Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2022 | 313,000 | 313,000 | - | - | Stock Option (right to buy) | |
| Rein Therapeutics Inc. | Allen Annis | SVP, Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 474,000 | 474,000 | - | - | Stock Option (right to buy) |